Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
LuciusVersionofDaprodustat:DosageandAdministration,Indications,PrecautionsDaprodustat is indicated for the treatment of anemia caused by chronic kidney disease in adult patients wh···【more】
Article source：Captain MedicineRelease date：2025-12-17Recommended：149
LuciusVersionofDacomitinib:DosageandAdministration,Indications,PrecautionsIndicationsDacomitinib is indicated for the first-line treatment of patients with metastatic non-small cel···【more】
Article source：Captain MedicineRelease date：2025-12-17Recommended：215
Lucius Version of Momelotinib: Dosage and Administration, Indications, PrecautionsIndicationsMomelotinib is indicated for the treatment of adult patients with anemia associated wit···【more】
Article source：Captain MedicineRelease date：2025-12-16Recommended：151
LuciusVersionofPirtobrutinib:DosageandAdministration,Indications,PrecautionsIndicationsPirtobrutinib is indicated for the treatment of adult patients with relapsed or refractory ma···【more】
Article source：Captain MedicineRelease date：2025-12-16Recommended：184
LuciusVersionofVALCYTE:DosageandAdministration,Indications,PrecautionsIndicationsAdult Patients① Treatment of CMV Retinitis in patients with AIDS;② Prevention of cytomegalovirus di···【more】
Article source：Captain MedicineRelease date：2025-12-15Recommended：156
LuciusVersionofVemurafenib:DosageandAdministration,Indications,PrecautionsIndicationsVemurafenib is a kinase inhibitor indicated for the treatment of patients with unresectable or ···【more】
Article source：Captain MedicineRelease date：2025-12-15Recommended：156
LuciusVersionofCeritinib:DosageandAdministration,Indications,PrecautionsIndicationsCeritinib is a kinase inhibitor indicated for the treatment of adult patients with metastatic non···【more】
Article source：Captain MedicineRelease date：2025-12-12Recommended：150
LuciusVersionofAlectinib:DosageandAdministration,Indications,PrecautionsIndicationsAlectinib is a kinase inhibitor indicated for:Adjuvant treatment in adult patients with resected ···【more】
Article source：Captain MedicineRelease date：2025-12-12Recommended：154
LuciusVersionofTrelagliptin:DosageandAdministration,Indications,PrecautionsIndicationsTrelagliptin can be used as an adjunct to diet and exercise to improve glycemic control in adu···【more】
Article source：Captain MedicineRelease date：2025-12-11Recommended：168
LuciusVersionofAfatinib:DosageandAdministration,Indications,PrecautionsIndicationsAfatinib is a kinase inhibitor indicated for:First-line treatment of patients with metastatic non-···【more】
Article source：Captain MedicineRelease date：2025-12-11Recommended：165
LuciusVersionofFilgotinib:DosageandAdministration,Indications,PrecautionsIndicationsRheumatoid ArthritisLuciFilgo is indicated for the treatment of adult patients with moderately t···【more】
Article source：Captain MedicineRelease date：2025-12-10Recommended：154
LuciusVersionofFezolinetant:DosageandAdministration,Indications,PrecautionsIndicationsFezolinetant is the first non-hormonal therapy for the treatment of moderate to severe vasomot···【more】
Article source：Captain MedicineRelease date：2025-12-10Recommended：229
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：4502025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：6372024-09-07
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combinati···【more】
Recommended：942026-01-06
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：4162025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：4382025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：4212025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：4772025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3862025-01-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
